All CIRM Grants

Search Filters »

Institution Researcher name Grant Type Grant Title Award Value
University of California, Irvine Leif A Havton Early Translational II Repair of Conus Medullaris/Cauda Equina Injury using Human ES Cell-Derived Motor Neurons $1,527,011
City of Hope, Beckman Research Institute Dr. Yanhong Shi Ph.D. Early Translational II Developing a therapeutic candidate for Canavan disease using induced pluripotent stem cell $1,835,983
City of Hope, Beckman Research Institute Dr. David Louis DiGiusto Early Translational II Development of RNA-based approaches to stem cell gene therapy for HIV $3,097,160
University of California, Davis Dr. Roslyn Rivkah Isseroff Early Translational II Bone Marrow Mesenchymal Stem Cells to Heal Chronic Diabetic Wounds $4,629,747
University of California, Los Angeles Dr. Noriyuki Kasahara Early Translational II Stem cell-based carriers for RCR vector delivery to glioblastoma $3,340,625
Salk Institute for Biological Studies Dr. Fred H Gage Early Translational II Crosstalk: Inflammation in Parkinson’s disease (PD) in a humanized in vitro model $2,472,839
University of California, Irvine Dr. Henry John Klassen Early Translational II Human retinal progenitor cells as candidate therapy for retinitis pigmentosa $1,803,768
Children’s Hospital of Los Angeles Dr. Markus Muschen Early Translational II Dual targeting of tyrosine kinase and BCL6 signaling for leukemia stem cell eradication $850,769
University of California, San Francisco Markus Muschen Early Translational II Dual targeting of tyrosine kinase and BCL6 signaling for leukemia stem cell eradication $2,756,536
Buck Institute for Age Research Dr. Xianmin Zeng Early Translational II Banking transplant ready dopaminergic neurons using a scalable process $4,983,013
iPierian, Inc. Dr. John Dimos Early Translational II New Drug Discovery for SMA using Patient-derived Induced Pluripotent Stem Cells $2,410,000
University of California, Los Angeles Prof. Bruno Peault Early Translational II Harnessing native fat-residing stem cells for bone regeneration $5,359,076
Scripps Research Institute Peter G. Schultz Early Translational II Cartilage Regeneration by the Chondrogenic Small Molecule PRO1 during Osteoarthritis $6,047,249
University of California, San Diego Professor Alysson R Muotri Early Translational II Developing a drug-screening system for Autism Spectrum Disorders using human neurons $1,376,198
University of California, Irvine Dr. Leslie M Thompson Early Translational II A hESc-based Development Candidate for Huntington’s Disease $3,955,038
University of California, San Diego Catriona Jamieson Early Translational II Preclinical development of a pan Bcl2 inhibitor for cancer stem cell directed therapy $3,103,041
Gladstone Institutes, J. David Dr. Todd C. McDevitt Research Leadership Engineering microscale tissue constructs from human pluripotent stem cells $5,849,100
University of California, Los Angeles Dr. John P Chute Research Leadership Niche-Focused Research: Discovery & Development of Hematopoietic Regenerative Factors $4,645,297
University of California, Berkeley Dr. Xavier Darzacq Research Leadership Single Molecule Biophysics and Biology of Cellular Identity $4,175,924
University of California, San Francisco Redacted Research Leadership Recapitulating development of the musculoskeletal axis in vitro with pluripotent cells $0
University of California, San Diego Dr. Eric T. Ahrens Research Leadership Molecular Imaging for Stem Cell Science and Clinical Application $5,680,474
University of California, Santa Cruz Professor Richard Gregory Research Leadership MicroRNA Regulation in Stem Cells, Development, and Disease $0
Stanford University Professor Hiromitsu Nakauchi Research Leadership Generation of functional cells and organs from iPSCs $5,426,135
Gladstone Institutes, J. David Dr. Kevin Kit Parker PhD Research Leadership Engineering Cardiac Tissue for Regeneration and Drug Development $0
Cedars-Sinai Medical Center Dr. Barry R Stripp Research Leadership Epithelial progenitors and the stromal niche as therapeutic targets in lung disease $4,841,830
Parkinson’s Institute Dennis Steindler Research Leadership Stem Cell Pathologies in Parkinson’s disease as a key to Regenerative Strategies $0
University of Southern California Dr. Andrew McMahon Research Leadership Repair and regeneration of the nephron $5,672,206
University of California, Berkeley Dr. Zhigang He Research Leadership Developing a regeneration-based functional restoration treatment for spinal cord injury $0
University of California, Santa Barbara Professor Peter J Coffey Research Leadership Development of Cellular Therapies for Retinal Disease $4,690,963
Sanford Burnham Prebys Medical Discovery Institute Dr. Robert J Wechsler-Reya Research Leadership The role of neural stem cells in cerebellar development, regeneration and tumorigenesis $5,226,049
Mohammad Pashmforoush Dr. Mohammad Pashmforoush New Faculty I Medical School Loan Repayment Program $27,949
Salk Institute for Biological Studies Dr. Dana Leanne Jones New Faculty I Characterization of mechanisms regulating de-differentiation and the re-acquisition of stem cell identity $2,134,100
University of California, Los Angeles Dr. Dana Leanne Jones New Faculty I Characterization of mechanisms regulating de-differentiation and the re-acquisition of stem cell identity $382,773
University of California, Los Angeles Dr. Siavash Kurdistani New Faculty I Epigenetics in cancer stem cell initiation and clinical outcome prediction $3,063,450
University of California, Santa Cruz Dr. Camilla Forsberg New Faculty I Mechanisms of Stem Cell Fate Decisions $2,201,759
University of Southern California Dr. Mohammad Pashmforoush New Faculty I Transcriptional Regulation of Cardiac Pacemaker Cell Progenitors $2,816,578
University of California, Berkeley Dr. Irina M. Conboy New Faculty I Identification of hESC-mediated molecular mechanism that positively regulates the regenerative capacity of post-natal tissues $2,246,020
University of California, Santa Cruz Dr. Bin Chen New Faculty I Molecular mechanisms of neural stem cell differentiation in the developing brain $2,147,592
University of California, Los Angeles Dr. Kathrin Plath Dr. New Faculty I In vitro reprogramming of mouse and human somatic cells to an embryonic state $2,229,427
The Regents of the University of California on behalf of its Riverside Campus Dr. Douglas Ethell New Faculty I ES-Derived Cells for the Treatment of Alzheimer’s Disease $621,639
Western University of Health Sciences Dr. Douglas W Ethell New Faculty I ES-Derived Cells for the Treatment of Alzheimer’s Disease $1,401,642
University of California, Davis Dr. Chong-Xian Pan New Faculty I Combinatorial Chemistry Approaches to Develop LIgands against Leukemia Stem Cells $2,386,409
University of California, Los Angeles Dr. Hanna Mikkola New Faculty I Mechanisms of Hematopoietic stem cell Specification and Self-Renewal $2,286,900
City of Hope, Beckman Research Institute Dr. Tiziano Barberi New Faculty I Skeletal muscle development from hESC and its in vivo applications in animal models of muscular dystrophy $131,840
Scripps Research Institute Dr. Kristin K Baldwin Dr. New Faculty I Generating pluripotent cell lines from neurons. $2,786,560
Salk Institute for Biological Studies Dr. Lei Wang New Faculty I Genetic Encoding Novel Amino Acids in Embryonic Stem Cells for Molecular Understanding of Differentiation to Dopamine Neurons $2,587,742
Stanford University Dr. Anne Brunet New Faculty I Molecular mechanisms involved in adult neural stem cell maintenance $2,348,435
University of California, Merced Dr Jennifer O Manilay New Faculty I Enhancing Survival of Embryonic Stem Cell-Derived Grafts by Induction of Immunological Tolerance $1,576,389
University of California, Irvine Dr. Andrew Putnam New Faculty I A Novel Engineered Niche to Explore the Vasculogenic Potential of Embryonic Stem Cells $395,764
Stanford University Dr. Joanna Wysocka PhD New Faculty I Trithorax and Polycomb methyltransferase complexes in cell fate determination. $2,373,903